Pertussis primary prevention

Jump to navigation Jump to search

_NOTOC__ Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Luke Rusowicz-Orazem, B.S.

Pertussis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Pertussis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pertussis primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pertussis primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pertussis primary prevention

CDC onPertussis primary prevention

Pertussis primary prevention in the news

Blogs on Pertussis primary prevention

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Pertussis primary prevention

Overview

The primary prevention method for Pertussis is vaccination using DTaP to immunize infants and children and TDap as a booster for adolescents and adults to bolster immunity. Additional measures include use of antibiotics in individuals with exposure to Pertussis patients, as well as practicing proper hygiene.

Primary Prevention

  • Effective measures of primary prevention for Pertussis are vaccinations:
    • DTaP: The combination Tetanus/Diptheria/Pertussis vaccine administered to infants and children for immunization.[1]
    • TDap: The Tetatnus/Diptheria/Pertussis booster administered to adolescents and adults in 10 year intervals to bolster and reinforce immunity.[1]
  • Antibiotics may be administered to family members of a Pertussis patient for prevention, especially to infants below the age of 1.[1]
    • Close contacts who receive appropriate antibioticsduring the 7–21 day incubation period may be protected from developing symptomatic disease. Close contacts are defined as anyone coming into contact with the respiratory secretions of an infected person in the 21 days before or after the infected person's cough began.[2]
  • Proper hygienic measures, including:[1]
    • Coughing and sneezing into a tissue or elbow
    • Thoroughly washing hands with soap and water
    • Using an alcohol-based sanitation fluid

References

  1. 1.0 1.1 1.2 1.3 "Vaccines: VPD-VAC/Pertussis/main page".
  2. Pertussis (whooping cough). Treatment. CDC.gov. Accessed on June 15, 2014

Template:WH Template:WS